Balance Sheet for TG Therapeutics Inc. (TGTX)

$ 18.65   -1.09 (-5.52%) Volume: 2.93m 4:00 PM EDT May 29, 2020
After Hours:  $ 18.73   0.08 (+0.43%) Volume: 92.2k 7:32 PM EDT May 29, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 112,637 41,958 56,718 25,031 55,061
Restrictable Cash - - - - -
Marketable Securities 27,798 26,943 27,999 19,854 22,167
Accounts Receivable - 95 108 84 186
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - 95 108 84 186
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 8,105 9,691 8,056 5,679 9,151
Current Deferred Income Taxes - - - - -
Other Current Assets 611 439 437 216 308
Total Current Assets 149,151 79,031 93,318 50,864 86,873
Land and Improvements - - - - -
Buildings and Improvement 2,129 2,294 2,429 2,042 -
Machinery, Furniture and Equipment 282 251 248 328 47
Construction in Progress - - - - -
Fixed Assets, Other 9,402 - - - -
Fixed Assets, Total 11,813 2,545 2,677 2,370 47
Gross Fixed Assets 11,813 2,545 2,677 2,370 47
Accumulated Depreciation - - - - -
Net Fixed Assets 11,813 2,545 2,677 2,370 47
Intangibles - - - - -
Cost in Excess 799 799 799 799 799
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 1,251 1,241 587 748 750
Total Non-Current Assets 13,863 4,585 4,063 3,917 26,600
Total Assets 163,014 83,616 97,381 54,782 113,473
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 30,041 36,377 25,877 15,268 9,346
Short Term Debt 1,616 67 128 69 212
Notes Payable - - - - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - 152 152 152 152
Current Deferred Income Taxes - - - - -
Other Current Liabilities 52,792 2,258 1,800 1,390 818
Total Current Liabilities 84,449 38,854 27,957 16,878 10,528
Long Term Debt 28,970 N/A - - -
Deferred Income Tax 762 2,376 2,431 2,035 1,371
Other Non-Current Liabilities 762 20,726 2,431 2,035 1,371
Minority Interest - - - - -
Capital Lease Obligations 10,218 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 39,950 20,726 2,431 2,035 1,371
Total Liabilities 124,399 59,580 30,388 18,914 11,900
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 38,615 24,036 66,993 35,868 101,573
Common Par 109 84 73 57 54
Additional Paid in Capital 739,956 552,531 422,017 272,432 259,887
Cumulative Translation Adjustments - - - - -
Retained Earnings (701,216) (528,345) (354,863) (236,387) (158,134)
Treasury Stock 234 234 234 234 234
Other Equity Adjustments - - - - -
Total Capitalization 67,585 24,036 66,993 35,868 101,573
Total Equity 38,615 24,036 66,993 35,868 101,573
Total Liabilities & Shareholder's Equity 163,014 83,616 97,381 54,782 113,473
Cash Flow (172,896) (173,586) (118,619) (78,775) (63,500)
Working Capital 64,702 40,177 65,361 33,986 76,345
Free Cash Flow (132,937) (129,015) (93,762) (61,935) (44,732)
Invested Capital 67,585 24,036 66,993 35,868 101,573
Shares Outstanding - Common Class Only 109,384 83,871 73,140 56,779 54,054
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 109,384 83,871 73,140 56,779 54,054
Total Common Shares Outstanding 109,384 83,871 73,140 56,779 54,054
Treasury Shares 41 41 41 41 41
Basic Weighted Shares Outstanding 88,369 75,467 62,070 49,041 45,646
Diluted Weighted Shares Outstanding 88,369 75,467 62,070 49,041 45,646